Aria Pharmaceuticals Company

Aria Pharmaceuticals is a preclinical-stage pharmaceutical company discovering and developing novel small molecule therapies for complex and hard-to-treat diseases. Too many patients today are in need of breakthrough treatments across many complicated diseases – they can't wait. That's why at Aria, we have redefined the drug discovery approach, saving years in the process and increasing success rates 30 times higher than traditional methods. At Aria, we've shown promise across a diverse range of therapeutic areas with the ability to address over 1,000 diseases.
Technology: Artificial Intelligence, Big Data, Biotechnology, Pharmaceutical
Industry: Early Drug Development, Preclinical Development
Headquarters: Palo Alto, California, United States
Founded Date: 2014-01-01
Employees Number: 11-50
Funding Status: Early Stage Venture
Investors Number: 5
Total Funding: 14300000
Estimated Revenue: Less than $1M
Last Funding Date: 2018-03-19
Last Funding Type: Series A

Visit Website
https://twitter.com/ariapharma
Register and Claim Ownership